在国家级的老年人处方计划中使用透皮尼古丁. 首先看看"现实世界"的补丁用户
1Fox Chase Cancer Center, Cheltenham, PA 19012.
JAMA
|February 23, 1994
概括
使用尼古丁贴片的老年吸烟者戒烟率为29%,但服从性很差. 增加医生和药剂师的联系改善了通过皮肤尼古丁治疗的结果.
科学领域:
- 老年学是指老年学的学科.
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
背景情况:
- 低收入的老年人是吸烟相关健康问题的脆弱人群.
- 通过皮肤注射的尼古丁贴片为这一群体提供了潜在的戒烟援助.
研究的目的:
- 评估通过皮肤治疗尼古丁治疗的使用模式和有效性.
- 确定影响老年低收入吸烟者戒烟的因素.
主要方法:
- 在1070名老年吸烟者 (65-74岁) 中进行了为期6个月的电话调查.
- 参与者通过宾夕法尼亚州老年人制药援助计划填写了通过皮肤注射尼古丁的处方.
- 收集的数据包括医生/药剂师的建议,辅助治疗,同时吸烟和6个月的戒烟.
主要成果:
- 受访者是长期,重度吸烟者,平均使用贴片5周.
- 观察到29%的自我报告的6个月戒烟率.
- 合规问题普遍存在:54%的人接受了初步咨询,<2%的人使用了正式计划,47%的人在使用贴片时吸烟. 同时吸烟与禁欲失败有关 (P < .001).
结论:
- 尼古丁贴片治疗对老年人来说是有前途的,但坚持和最佳使用需要注意.
- 频繁接触医疗保健提供者与减少同时吸烟和更高的戒烟率相关 (P = .005).
- 需要进一步的研究来完善这种人群的治疗策略.
更多相关视频
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
06:33Fabrication of Dissolvable Microneedle Patches Loaded with α-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction
Published on: December 30, 2025
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
